The effect of alpha1-AR antagonists for lower urinary tract symptoms in patients undergoing prostate 125I brachytherapy for prostate carcinoma.

Trial Profile

The effect of alpha1-AR antagonists for lower urinary tract symptoms in patients undergoing prostate 125I brachytherapy for prostate carcinoma.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2014

At a glance

  • Drugs Silodosin (Primary)
  • Indications Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 May 2012 Planned end date Apr 2013 added as reported by University Hospital Medical Information Network - Japan record.
    • 28 Feb 2012 Results presented at the 27th Congress of the European Association of Urology.
    • 18 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top